Leadership

Leadership

Founders


Jim Broderick
M.D., CEO and Founder

Carolyn Bertozzi
Ph.D., Co-Founder

Paul Crocker
Ph.D., Co-Founder

Board of Directors

  • Jim Broderick, M.D.
    Palleon Pharmaceuticals
  • Jens Eckstein, Ph.D.
    SR One
  • Steve Hoffman, M.D., Ph.D.
    Bicycle Therapeutics
  • Bill Burkoth
    Pfizer Ventures
  • James Lee
    Vertex Holdings
  • Karen Hong, Ph.D.
    Takeda Ventures, Inc.

Investors

Palleon is advancing its platform and programs with a $47.6 million Series A investment round that includes participation by:

Scientific Advisors

  • Carolyn Bertozzi Ph.D.
    Stanford University
  • Paul Crocker, Ph.D.
    University of Dundee
  • Joy Burchell, Ph.D.
    Kings College London
  • Jeffrey Ravetch, Ph.D.
    Rockefeller University
  • Heinz Läubli, M.D., Ph.D.
    University of Basel
  • Stephan von Gunten, M.D. Ph.D.
    University of Bern
  • Paul Moss, M.D., Ph.D.
    University of Birmingham
  • James Paulson, Ph.D.
    Scripps Research Institute
  • Peter Murray, Ph.D.
    Max Planck Institute